Fig. 1: Biomarker levels of NK cell activity and aberrant methylation of the HOXA9 promoter region. | British Journal of Cancer

Fig. 1: Biomarker levels of NK cell activity and aberrant methylation of the HOXA9 promoter region.

From: NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors

Fig. 1: Biomarker levels of NK cell activity and aberrant methylation of the HOXA9 promoter region.The alternative text for this image may have been generated using AI.

a Box plot illustrating the log10 transformed levels of interferon gamma (IFNγ) in pg/ml at baseline, before cycle 2, and before cycle 4, immediately after control CT scan. b Box plot illustrating the log10 transformed levels of methylated HOXA9 circulating tumor DNA in percent at the same time points as Fig. 1a.

Back to article page